cdmo.directory
← Compare landing

Esco Aster vs uBriGene

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryEsco AsteruBriGene
SummaryEsco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Clinical Trial Services
  • Translational Research
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Analytical Method Development & Validation
  • Translational Research
Modalities
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilitiesData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
Certifications
  • cGMP · Identifier: cGMP-compliant
  • GLP · Identifier: GLP Toxicology
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted

Find similar companies

Esco Aster alternatives · uBriGene alternatives

Markdown mirror: /compare/escoaster/ubrigene.md